Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2005 May 15;57(10):1209-11.
doi: 10.1016/j.biopsych.2005.02.007.

Acute Yohimbine Increases Laboratory-Measured Impulsivity in Normal Subjects

Clinical Trial

Acute Yohimbine Increases Laboratory-Measured Impulsivity in Normal Subjects

Alan C Swann et al. Biol Psychiatry. .


Background: State-dependent changes in impulsivity may be related to norepinephrine. To examine possible relationships between norepinephrine and acute changes in impulsivity, we measured effects of yohimbine, which increases norepinephrine release by blocking alpha-2 noradrenergic receptors, on laboratory-measured impulsivity in healthy subjects without psychiatric or substance-use disorders.

Methods: Impulsivity was assessed using the Immediate and Delayed Memory Tasks (IMT-DMT), derived from the Continuous Performance Test, before and after placebo or two doses of yohimbine, given 4 days apart. Blood pressure was monitored, and psychiatric symptoms were measured using self-rated visual analog scales.

Results: Yohimbine was associated with a dose-related increase in impulsive IMT commission errors, with an increase of > 50% relative to baseline at the higher dose. The activation factor of the Internal State Scale was increased at the same dose.

Conclusions: These results are consistent with increased impulsivity in normal subjects given yohimbine, possibly related to increased norepinephrine.

Similar articles

See all similar articles

Cited by 32 articles

See all "Cited by" articles

Publication types

LinkOut - more resources